Mid-Florida Hem Oncology Ctr — Orange City, Florida

Mid-Florida Hem Oncology Ctr is a clinical research site located in Orange City, Florida, United States 32763.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-Florida Hem Oncology Ctr has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer.

Sponsors: Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orange City

Browse all research sites in Florida · View every site in Orange City

• Florida Hospital Medical Group-Lake Mary Pediatrics
• Florida Hospital FISH
• Medical Research Group of Central Florida
• Mid Florida Hematology and Oncology Center
• Research Site
• Optimal Research Sites
• Florida Cancer Specialists
• Pfizer Investigational Site
• Mid-Florida Cancer Centers
• Lake Mary Pediatrics
• GSK Investigational Site
• Mid-Florida Hematology and Oncology Centers

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Florida Hem Oncology Ctr?

Mid-Florida Hem Oncology Ctr has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Florida Hem Oncology Ctr conducted?

Mid-Florida Hem Oncology Ctr has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer.

Is Mid-Florida Hem Oncology Ctr accredited by Crixeo Clinical Trials?

Mid-Florida Hem Oncology Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Florida Hem Oncology Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.